Immunoassays – News and Features

Researchers have discovered a set of alterations in the structure and cellular makeup of breast connective tissue – known as stromal tissue – linked to a higher risk of aggressive breast cancer and poorer survival outcomes.

Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition.

Researchers have developed a dental floss pick that also featured a sensor that can detect high cortisol levels in a person's saliva. The flosser can provide early warnings for chronic stress, and could be adapted to other biomarkers.

University of Cincinnati engineers created a new device to help doctors diagnose depression and anxiety.

Researchers have uncovered the molecular mechanisms that cause a commonly prescribed antipsychotic drug to produce harmful side effects similar to Parkinson’s disease symptoms.

Researchers have developed a chemical probe to study a key component of the Mycobacterium tuberculosis envelope. Their results provide a step toward finding new ways of inactivating the bacterium.

As well as providing energy to the cell, glycolysis also controls cell fate in early embryonic development, laying the foundation for future organ development.

A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II clinical trials in Malawi and Tanzania.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

Researchers at UCSF discovered that regulatory T cells (T-regs) in the meninges produce natural opioids, and their pain-suppressing effects are influenced by estrogen and progesterone.